Evolent Health, Inc. (NYSE: EVH), a company providing an integrated value-based care platform to the nation's leading health systems and physician organizations announced the pricing of an underwritten secondary public offering of 4,500,000 shares of its Class A common stock to be sold by certain affiliates of TPG Global, LLC and Ptolemy Capital, LLC. The shares of Class A common stock are being sold to the public at a price of $25.90 per share.

The offering is expected to close on June 28, 2017, subject to the satisfaction of customary closing conditions.

Goldman Sachs & Co. LLC and Morgan Stanley are acting as book-running managers and underwriters for the offering.

Neither Evolent Health nor any of its directors, officers or other stockholders is offering any shares of Class A common stock in the offering. Evolent Health will not receive any proceeds from the sale of shares of Class A common stock by the Selling Stockholders.

About Evolent Health

Evolent Health partners with leading health systems to drive value-based care transformation. By providing clinical, analytical and financial capabilities, Evolent Health helps physicians and health systems achieve superior quality and cost results. Evolent Health's approach breaks down barriers, aligns incentives and powers a new model of care delivery resulting in meaningful alignment between providers, payers, physicians and patients.